-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
We know that in respiratory viral infections such as influenza , bacterial superinfection can lead to higher morbidity and mortality, requiring prompt diagnosis and initiation of antibiotic therapy (ABT), and studies have shown that bacterial co-infection in patients with COVID-19 infection and The rate of superinfection was less than 10%, but the percentage of systemic ABT was over 60%
Figure: Comparison of the prognosis of patients with new coronary pneumonia
Coronavirus disease
Maximilian J.
All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort